Rochester Clinical Research, Inc

Summary

Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Migraine, Flu, Obesity, Vestibular Migraine, Childhood Obesity and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 232 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Jonathan Goldstein.

Top PIs

Clinical Trials running at Rochester Clinical Research, Inc

Obesity

COVID-19

Hypertension

Cardiovascular Disease

High Blood Pressure

Childhood Obesity

I Am A Healthy Volunteer

Liver Cancer

Coronavirus Infection

Vestibular Migraine

Maridebart Cafraglutide

for Cardiovascular Disease

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.

Recruiting

1 award

Phase 3

2 criteria

Orforglipron

for High Blood Pressure

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.

Recruiting

1 award

Phase 3

LY3305677

for Obesity

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.

Recruiting

0 awards

Phase 2

3 criteria